TY - JOUR AU - McGuire, W. P. AU - Hoskins, W. J. AU - Brady, M. F. AU - Kucera, P. R. AU - Partridge, E. E. AU - Look, K. Y. AU - Clarke-Pearson, D. L. AU - Davidson, M. PY - 1996 DA - 1996// TI - Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group) JO - Semin Oncol VL - 23 ID - McGuire1996 ER - TY - JOUR AU - Piccart, M. J. AU - Bertelsen, K. AU - James, K. AU - Cassidy, J. AU - Mangioni, C. AU - Simonsen, E. AU - Stuart, G. AU - Kaye, S. AU - Vergote, I. AU - Blom, R. PY - 2000 DA - 2000// TI - Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results JO - J Natl Cancer Inst VL - 92 UR - https://doi.org/10.1093/jnci/92.9.699 DO - 10.1093/jnci/92.9.699 ID - Piccart2000 ER - TY - JOUR AU - Heintz, A. P. M. AU - Odicino, F. AU - Maisonneuve, P. AU - Quinn, M. A. AU - Benedet, J. L. AU - Creasman, W. T. AU - Ngain, H. Y. S. AU - Pecorelli, S. AU - Beller, U. PY - 2006 DA - 2006// TI - Carcinoma of the ovary JO - Int J Gynaecol Obstet VL - 95 Suppl 1 UR - https://doi.org/10.1016/S0020-7292(06)60033-7 DO - 10.1016/S0020-7292(06)60033-7 ID - Heintz2006 ER - TY - JOUR AU - Nogales, E. AU - Wolf, S. G. AU - Downing, K. H. PY - 1998 DA - 1998// TI - Structure of the alpha beta tubulin dimer by electron crystallography JO - Nature VL - 391 UR - https://doi.org/10.1038/34465 DO - 10.1038/34465 ID - Nogales1998 ER - TY - JOUR AU - Galletti, E. AU - Magnani, M. AU - Renzulli, M. L. AU - Botta, M. PY - 2007 DA - 2007// TI - Paclitaxel and docetaxel resistance: molecular mechanisms and development of new generation taxanes JO - ChemMedChem VL - 2 UR - https://doi.org/10.1002/cmdc.200600308 DO - 10.1002/cmdc.200600308 ID - Galletti2007 ER - TY - JOUR AU - Luqmani, Y. A. PY - 2005 DA - 2005// TI - Mechanisms of drug resistance in cancer chemotherapy JO - Med Princ Pract VL - 14 ID - Luqmani2005 ER - TY - JOUR AU - Barry, M. A. AU - Behnke, C. A. AU - Eastman, A. PY - 1990 DA - 1990// TI - Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia JO - Biochem Pharmacol VL - 40 UR - https://doi.org/10.1016/0006-2952(90)90733-2 DO - 10.1016/0006-2952(90)90733-2 ID - Barry1990 ER - TY - JOUR AU - Ferry, K. V. AU - Hamilton, T. C. AU - Johnson, S. W. PY - 2000 DA - 2000// TI - Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells: role of ERCC1-XPF JO - Biochem Pharmacol VL - 60 UR - https://doi.org/10.1016/S0006-2952(00)00441-X DO - 10.1016/S0006-2952(00)00441-X ID - Ferry2000 ER - TY - JOUR AU - Perego, P. AU - Giarola, M. AU - Righetti, S. C. AU - Supino, R. AU - Caserini, C. AU - Delia, D. AU - Pierotti, M. A. AU - Miyashita, T. AU - Reed, J. C. AU - Zunino, F. PY - 1996 DA - 1996// TI - Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems JO - Cancer Res VL - 56 ID - Perego1996 ER - TY - JOUR AU - Godwin, A. K. AU - Meister, A. AU - O'Dwyer, P. J. AU - Huang, C. S. AU - Hamilton, T. C. AU - Anderson, M. E. PY - 1992 DA - 1992// TI - High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis JO - Proc Natl Acad Sci USA VL - 89 UR - https://doi.org/10.1073/pnas.89.7.3070 DO - 10.1073/pnas.89.7.3070 ID - Godwin1992 ER - TY - JOUR AU - Katano, K. AU - Safaei, R. AU - Samimi, G. AU - Holzer, A. AU - Rochdi, M. AU - Howell, S. B. PY - 2003 DA - 2003// TI - The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells JO - Mol Pharmacol VL - 64 UR - https://doi.org/10.1124/mol.64.2.466 DO - 10.1124/mol.64.2.466 ID - Katano2003 ER - TY - JOUR AU - Bernardini, M. AU - Lee, C. H. AU - Beheshti, B. AU - Prasad, M. AU - Albert, M. AU - Marrano, P. AU - Begley, H. AU - Shaw, P. AU - Covens, A. AU - Murphy, J. PY - 2005 DA - 2005// TI - High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer JO - Neoplasia VL - 7 UR - https://doi.org/10.1593/neo.04760 DO - 10.1593/neo.04760 ID - Bernardini2005 ER - TY - JOUR AU - Kim, S. W. AU - Kim, J. W. AU - Kim, Y. T. AU - Kim, J. H. AU - Kim, S. AU - Yoon, B. S. AU - Nam, E. J. AU - Kim, H. Y. PY - 2007 DA - 2007// TI - Analysis of chromosomal changes in serous ovarian carcinoma using high-resolution array comparative genomic hybridization: Potential predictive markers of chemoresistant disease JO - Genes Chromosomes Cancer VL - 46 UR - https://doi.org/10.1002/gcc.20384 DO - 10.1002/gcc.20384 ID - Kim2007 ER - TY - JOUR AU - Prasad, M. AU - Bernardini, M. AU - Tsalenko, A. AU - Marrano, P. AU - Paderova, J. AU - Lee, C. H. AU - Ben-Dor, A. AU - Barrett, M. T. AU - Squire, J. A. PY - 2008 DA - 2008// TI - High definition cytogenetics and oligonucleotide aCGH analyses of cisplatin-resistant ovarian cancer cells JO - Genes Chromosomes Cancer VL - 47 UR - https://doi.org/10.1002/gcc.20547 DO - 10.1002/gcc.20547 ID - Prasad2008 ER - TY - JOUR AU - Osterberg, L. AU - Levan, K. AU - Partheen, K. AU - Staaf, J. AU - Sundfeldt, K. AU - Horvath, G. PY - 2009 DA - 2009// TI - High-resolution genomic profiling of carboplatin resistance in early-stage epithelial ovarian carcinoma JO - Cytogenet Genome Res VL - 125 UR - https://doi.org/10.1159/000218744 DO - 10.1159/000218744 ID - Osterberg2009 ER - TY - JOUR AU - Kudoh, K. AU - Takano, M. AU - Koshikawa, T. AU - Hirai, M. AU - Yoshida, S. AU - Mano, Y. AU - Yamamoto, K. AU - Ishii, K. AU - Kita, T. AU - Kikuchi, Y. PY - 1999 DA - 1999// TI - Gains of 1q21-q22 and 13q12-q14 are potential indicators for resistance to cisplatin-based chemotherapy in ovarian cancer patients JO - Clin Cancer Res VL - 5 ID - Kudoh1999 ER - TY - JOUR AU - Wasenius, V. M. AU - Jekunen, A. AU - Monni, O. AU - Joensuu, H. AU - Aebi, S. AU - Howell, S. B. AU - Knuutila, S. PY - 1997 DA - 1997// TI - Comparative genomic hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cells JO - Genes Chromosomes Cancer VL - 18 UR - https://doi.org/3.0.CO;2-X DO - 3.0.CO;2-X ID - Wasenius1997 ER - TY - JOUR AU - Takano, M. AU - Kudo, K. AU - Goto, T. AU - Yamamoto, K. AU - Kita, T. AU - Kikuchi, Y. PY - 2001 DA - 2001// TI - Analyses by comparative genomic hybridization of genes relating with cisplatin-resistance in ovarian cancer JO - Hum Cell VL - 14 ID - Takano2001 ER - TY - JOUR AU - Osterberg, L. AU - Levan, K. AU - Partheen, K. AU - Helou, K. AU - Horvath, G. PY - 2005 DA - 2005// TI - Cytogenetic analysis of carboplatin resistance in early-stage epithelial ovarian carcinoma JO - Cancer Genet Cytogenet VL - 163 UR - https://doi.org/10.1016/j.cancergencyto.2005.06.023 DO - 10.1016/j.cancergencyto.2005.06.023 ID - Osterberg2005 ER - TY - JOUR AU - Jonsson, G. AU - Staaf, J. AU - Olsson, E. AU - Heidenblad, M. AU - Vallon-Christersson, J. AU - Osoegawa, K. AU - de Jong, P. AU - Oredsson, S. AU - Ringner, M. AU - Hoglund, M. PY - 2007 DA - 2007// TI - High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization JO - Genes Chromosomes Cancer VL - 46 UR - https://doi.org/10.1002/gcc.20438 DO - 10.1002/gcc.20438 ID - Jonsson2007 ER - TY - STD TI - Saal LH, Troein C, Vallon-Christersson J, Gruvberger S, Borg A, Peterson C: BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data. Genome Biology. 2002, 3 (8): 10.1186/gb-2002-3-8-software0003. ID - ref21 ER - TY - JOUR AU - Staaf, J. AU - Jonsson, G. AU - Ringner, M. AU - Vallon-Christersson, J. PY - 2007 DA - 2007// TI - Normalization of array-CGH data: influence of copy number imbalances JO - BMC Genomics VL - 8 UR - https://doi.org/10.1186/1471-2164-8-382 DO - 10.1186/1471-2164-8-382 ID - Staaf2007 ER - TY - JOUR AU - Autio, R. AU - Hautaniemi, S. AU - Kauraniemi, P. AU - Yli-Harja, O. AU - Astola, J. AU - Wolf, M. AU - Kallioniemi, A. PY - 2003 DA - 2003// TI - CGH-Plotter: MATLAB toolbox for CGH-data analysis JO - Bioinformatics VL - 19 UR - https://doi.org/10.1093/bioinformatics/btg230 DO - 10.1093/bioinformatics/btg230 ID - Autio2003 ER - TY - JOUR AU - Gunnarsson, R. AU - Staaf, J. AU - Jansson, M. AU - Ottesen, A. M. AU - Goransson, H. AU - Liljedahl, U. AU - Ralfkiaer, U. AU - Mansouri, M. AU - Buhl, A. M. AU - Smedby, K. E. PY - 2008 DA - 2008// TI - Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia--a comparative study of four differently designed, high resolution microarray platforms JO - Genes Chromosomes Cancer VL - 47 UR - https://doi.org/10.1002/gcc.20575 DO - 10.1002/gcc.20575 ID - Gunnarsson2008 ER - TY - JOUR AU - Willenbrock, H. AU - Fridlyand, J. PY - 2005 DA - 2005// TI - A comparison study: applying segmentation to array CGH data for downstream analyses JO - Bioinformatics VL - 21 UR - https://doi.org/10.1093/bioinformatics/bti677 DO - 10.1093/bioinformatics/bti677 ID - Willenbrock2005 ER - TY - JOUR AU - Frank, E. AU - Hall, M. AU - Trigg, L. AU - Holmes, G. AU - Witten, I. H. PY - 2004 DA - 2004// TI - Data mining in bioinformatics using Weka JO - Bioinformatics VL - 20 UR - https://doi.org/10.1093/bioinformatics/bth261 DO - 10.1093/bioinformatics/bth261 ID - Frank2004 ER - TY - JOUR AU - Partheen, K. AU - Levan, K. AU - Osterberg, L. AU - Helou, K. AU - Horvath, G. PY - 2004 DA - 2004// TI - Analysis of cytogenetic alterations in stage III serous ovarian adenocarcinoma reveals a heterogeneous group regarding survival, surgical outcome, and substage JO - Genes Chromosomes Cancer VL - 40 UR - https://doi.org/10.1002/gcc.20053 DO - 10.1002/gcc.20053 ID - Partheen2004 ER - TY - JOUR AU - Gehan, E. A. PY - 1965 DA - 1965// TI - A Generalized Wilcoxon Test for Comparing Arbitrarily Singly-Censored Samples JO - Biometrika VL - 52 UR - https://doi.org/10.1093/biomet/52.1-2.203 DO - 10.1093/biomet/52.1-2.203 ID - Gehan1965 ER - TY - JOUR AU - Partheen, K. AU - Levan, K. AU - Osterberg, L. AU - Horvath, G. PY - 2006 DA - 2006// TI - Expression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors JO - Eur J Cancer VL - 42 UR - https://doi.org/10.1016/j.ejca.2006.06.026 DO - 10.1016/j.ejca.2006.06.026 ID - Partheen2006 ER - TY - JOUR AU - Nanjundan, M. AU - Nakayama, Y. AU - Cheng, K. W. AU - Lahad, J. AU - Liu, J. AU - Lu, K. AU - Kuo, W. L. AU - Smith-McCune, K. AU - Fishman, D. AU - Gray, J. W. PY - 2007 DA - 2007// TI - Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer JO - Cancer Res VL - 67 UR - https://doi.org/10.1158/0008-5472.CAN-06-2366 DO - 10.1158/0008-5472.CAN-06-2366 ID - Nanjundan2007 ER - TY - JOUR AU - Sunde, J. S. AU - Donninger, H. AU - Wu, K. AU - Johnson, M. E. AU - Pestell, R. G. AU - Rose, G. S. AU - Mok, S. C. AU - Brady, J. AU - Bonome, T. AU - Birrer, M. J. PY - 2006 DA - 2006// TI - Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-06-0683 DO - 10.1158/0008-5472.CAN-06-0683 ID - Sunde2006 ER - TY - JOUR AU - Brooks, D. J. AU - Woodward, S. AU - Thompson, F. H. AU - Dos Santos, B. AU - Russell, M. AU - Yang, J. M. AU - Guan, X. Y. AU - Trent, J. AU - Alberts, D. S. AU - Taetle, R. PY - 1996 DA - 1996// TI - Expression of the zinc finger gene EVI-1 in ovarian and other cancers JO - Br J Cancer VL - 74 UR - https://doi.org/10.1038/bjc.1996.583 DO - 10.1038/bjc.1996.583 ID - Brooks1996 ER - TY - JOUR AU - Liu, Y. AU - Chen, L. AU - Ko, T. C. AU - Fields, A. P. AU - Thompson, E. A. PY - 2006 DA - 2006// TI - Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K/AKT JO - Oncogene VL - 25 UR - https://doi.org/10.1038/sj.onc.1209403 DO - 10.1038/sj.onc.1209403 ID - Liu2006 ER - TY - JOUR AU - Soubeyran, P. AU - Kowanetz, K. AU - Szymkiewicz, I. AU - Langdon, W. Y. AU - Dikic, I. PY - 2002 DA - 2002// TI - Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors JO - Nature VL - 416 UR - https://doi.org/10.1038/416183a DO - 10.1038/416183a ID - Soubeyran2002 ER - TY - JOUR AU - Cao, C. AU - Lu, S. AU - Sowa, A. AU - Kivlin, R. AU - Amaral, A. AU - Chu, W. AU - Yang, H. AU - Di, W. AU - Wan, Y. PY - 2008 DA - 2008// TI - Priming with EGFR tyrosine kinase inhibitor and EGF sensitizes ovarian cancer cells to respond to chemotherapeutical drugs JO - Cancer Lett VL - 266 UR - https://doi.org/10.1016/j.canlet.2008.02.062 DO - 10.1016/j.canlet.2008.02.062 ID - Cao2008 ER - TY - JOUR AU - Chan, J. K. AU - Pham, H. AU - You, X. J. AU - Cloven, N. G. AU - Burger, R. A. AU - Rose, G. S. AU - Van Nostrand, K. AU - Korc, M. AU - Disaia, P. J. AU - Fan, H. PY - 2005 DA - 2005// TI - Suppression of ovarian cancer cell tumorigenicity and evasion of Cisplatin resistance using a truncated epidermal growth factor receptor in a rat model JO - Cancer Res VL - 65 ID - Chan2005 ER - TY - JOUR AU - Huang, K. C. AU - Rao, P. H. AU - Lau, C. C. AU - Heard, E. AU - Ng, S. K. AU - Brown, C. AU - Mok, S. C. AU - Berkowitz, R. S. AU - Ng, S. W. PY - 2002 DA - 2002// TI - Relationship of XIST expression and responses of ovarian cancer to chemotherapy JO - Mol Cancer Ther VL - 1 ID - Huang2002 ER - TY - JOUR AU - Hartmann, L. C. AU - Lu, K. H. AU - Linette, G. P. AU - Cliby, W. A. AU - Kalli, K. R. AU - Gershenson, D. AU - Bast, R. C. AU - Stec, J. AU - Iartchouk, N. AU - Smith, D. I. PY - 2005 DA - 2005// TI - Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-04-1673 DO - 10.1158/1078-0432.CCR-04-1673 ID - Hartmann2005 ER - TY - JOUR AU - Tetu, B. AU - Popa, I. AU - Bairati, I. AU - L'Esperance, S. AU - Bachvarova, M. AU - Plante, M. AU - Harel, F. AU - Bachvarov, D. PY - 2008 DA - 2008// TI - Immunohistochemical analysis of possible chemoresistance markers identified by micro-arrays on serous ovarian carcinomas JO - Mod Pathol VL - 21 UR - https://doi.org/10.1038/modpathol.2008.80 DO - 10.1038/modpathol.2008.80 ID - Tetu2008 ER - TY - JOUR AU - Yang, Y. L. AU - Chu, J. Y. AU - Luo, M. L. AU - Wu, Y. P. AU - Zhang, Y. AU - Feng, Y. B. AU - Shi, Z. Z. AU - Xu, X. AU - Han, Y. L. AU - Cai, Y. PY - 2008 DA - 2008// TI - Amplification of PRKCI, located in 3q26, is associated with lymph node metastasis in esophageal squamous cell carcinoma JO - Genes Chromosomes Cancer VL - 47 UR - https://doi.org/10.1002/gcc.20514 DO - 10.1002/gcc.20514 ID - Yang2008 ER - TY - JOUR AU - Gray, J. W. AU - Suzuki, S. AU - Kuo, W. L. AU - Polikoff, D. AU - Deavers, M. AU - Smith-McCune, K. AU - Berchuck, A. AU - Pinkel, D. AU - Albertson, D. AU - Mills, G. B. PY - 2003 DA - 2003// TI - Specific keynote: genome copy number abnormalities in ovarian cancer JO - Gynecol Oncol VL - 88 UR - https://doi.org/10.1006/gyno.2002.6677 DO - 10.1006/gyno.2002.6677 ID - Gray2003 ER - TY - JOUR AU - Larramendy, M. L. AU - Lushnikova, T. AU - Bjorkqvist, A. M. AU - Wistuba, I. I. AU - Virmani, A. K. AU - Shivapurkar, N. AU - Gazdar, A. F. AU - Knuutila, S. PY - 2000 DA - 2000// TI - Comparative genomic hybridization reveals complex genetic changes in primary breast cancer tumors and their cell lines JO - Cancer Genet Cytogenet VL - 119 UR - https://doi.org/10.1016/S0165-4608(99)00226-5 DO - 10.1016/S0165-4608(99)00226-5 ID - Larramendy2000 ER - TY - JOUR AU - Nucifora, G. AU - Laricchia-Robbio, L. AU - Senyuk, V. PY - 2006 DA - 2006// TI - EVI1 and hematopoietic disorders: history and perspectives JO - Gene VL - 368 UR - https://doi.org/10.1016/j.gene.2005.09.020 DO - 10.1016/j.gene.2005.09.020 ID - Nucifora2006 ER - TY - JOUR AU - Yokoi, S. AU - Yasui, K. AU - Iizasa, T. AU - Imoto, I. AU - Fujisawa, T. AU - Inazawa, J. PY - 2003 DA - 2003// TI - TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small cell lung cancers JO - Clin Cancer Res VL - 9 ID - Yokoi2003 ER - TY - JOUR AU - Morishita, K. AU - Parganas, E. AU - Douglass, E. C. AU - Ihle, J. N. PY - 1990 DA - 1990// TI - Unique expression of the human Evi-1 gene in an endometrial carcinoma cell line: sequence of cDNAs and structure of alternatively spliced transcripts JO - Oncogene VL - 5 ID - Morishita1990 ER - TY - JOUR AU - Fears, S. AU - Mathieu, C. AU - Zeleznik-Le, N. AU - Huang, S. AU - Rowley, J. D. AU - Nucifora, G. PY - 1996 DA - 1996// TI - Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family JO - Proc Natl Acad Sci USA VL - 93 UR - https://doi.org/10.1073/pnas.93.4.1642 DO - 10.1073/pnas.93.4.1642 ID - Fears1996 ER - TY - JOUR AU - Kaye, S. B. PY - 2008 DA - 2008// TI - Reversal of drug resistance in ovarian cancer: where do we go from here? JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2008.16.2123 DO - 10.1200/JCO.2008.16.2123 ID - Kaye2008 ER - TY - JOUR AU - Wang, Y. C. AU - Juric, D. AU - Francisco, B. AU - Yu, R. X. AU - Duran, G. E. AU - Chen, G. K. AU - Chen, X. AU - Sikic, B. I. PY - 2006 DA - 2006// TI - Regional activation of chromosomal arm 7q with and without gene amplification in taxane-selected human ovarian cancer cell lines JO - Genes Chromosomes Cancer VL - 45 UR - https://doi.org/10.1002/gcc.20300 DO - 10.1002/gcc.20300 ID - Wang2006 ER - TY - JOUR AU - Yabuki, N. AU - Sakata, K. AU - Yamasaki, T. AU - Terashima, H. AU - Mio, T. AU - Miyazaki, Y. AU - Fujii, T. AU - Kitada, K. PY - 2007 DA - 2007// TI - Gene amplification and expression in lung cancer cells with acquired paclitaxel resistance JO - Cancer Genet Cytogenet VL - 173 UR - https://doi.org/10.1016/j.cancergencyto.2006.07.020 DO - 10.1016/j.cancergencyto.2006.07.020 ID - Yabuki2007 ER - TY - JOUR AU - Kitada, K. AU - Yamasaki, T. PY - 2008 DA - 2008// TI - The complicated copy number alterations in chromosome 7 of a lung cancer cell line is explained by a model based on repeated breakage-fusion-bridge cycles JO - Cancer Genet Cytogenet VL - 185 UR - https://doi.org/10.1016/j.cancergencyto.2008.04.005 DO - 10.1016/j.cancergencyto.2008.04.005 ID - Kitada2008 ER - TY - JOUR AU - Codegoni, A. M. AU - Broggini, M. AU - Pitelli, M. R. AU - Pantarotto, M. AU - Torri, V. AU - Mangioni, C. AU - D'Incalci, M. PY - 1997 DA - 1997// TI - Expression of genes of potential importance in the response to chemotherapy and DNA repair in patients with ovarian cancer JO - Gynecol Oncol VL - 65 UR - https://doi.org/10.1006/gyno.1996.4609 DO - 10.1006/gyno.1996.4609 ID - Codegoni1997 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/9/368/prepub UR - http://www.biomedcentral.com/1471-2407/9/368/prepub ID - ref52 ER -